trial
Eczema drug Kymera succeeds in first trial, could rival Dupixent
Kymera Therapeutics announced Monday that, for the second time this year, it had successfully completed an early trial of a closely watched drug intended to rival Sanofi and Regeneron’s blockbuster treatment Dupixent. The phase 1 BroADen study enrolled 22 patients with moderate to severe eczema (atopic dermatitis), all of whom took Kymera’s investigational pill, KT-621. […]
1 min read
Elevance loses the Medicare trial advantage Star Ratings
Bob Herman covers health insurance, government programs, hospitals, doctors and other suppliers – reporting how money influences these companies and shaping what we all pay for care. He is also the author of The Health Care Inc. Newsletter. You can reach Bob on the signal on Bobjherman.09. A Federal Judge of Texas canceled the Health […]
1 min read